A citation-based method for searching scientific literature

Mary Jo Lund, Katrina F Trivers, Peggy L Porter, Ralph J Coates, Brian Leyland-Jones, Otis W Brawley, Elaine W Flagg, Ruth M O'Regan, Sheryl G A Gabram, J William Eley. Breast Cancer Res Treat 2009
Times Cited: 278

Rowan T Chlebowski, Zhao Chen, Garnet L Anderson, Thomas Rohan, Aaron Aragaki, Dorothy Lane, Nancy C Dolan, Electra D Paskett, Anne McTiernan, F Alan Hubbell, Lucile L Adams-Campbell, Ross Prentice. J Natl Cancer Inst 2005
Times Cited: 444

List of shared articles

Times cited

Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.
Julia Foldi, Adriana Kahn, Andrea Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar,[...]. Clin Cancer Res 2022

Differences in Breast Cancer Presentation at Time of Diagnosis for Black and White Women in High Resource Settings.
Jo-Ann Osei-Twum, Sahra Gedleh, Aisha Lofters, Onye Nnorom. J Immigr Minor Health 2021

Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study.
Xiaozhu Liu, Song Yue, Haodong Huang, Minjie Duan, Binyi Zhao, Jin Liu, Tianyu Xiang. Front Med (Lausanne) 2021

Genomic analysis of racial differences in triple negative breast cancer.
Chang-Sheng Chang, Eiko Kitamura, Joan Johnson, Roni Bollag, Lesleyann Hawthorn. Genomics 2019

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.
Brittany D Jenkins, Rachel N Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W Howerth, Mary Egan, Jamie Hodgson, Clayton Yates,[...]. Cancer Epidemiol Biomarkers Prev 2019

Examining Mammography Use by Breast Cancer Risk, Race, Nativity, and Socioeconomic Status.
Bilikisu R Elewonibi, Amy D Thierry, Patricia Y Miranda. J Immigr Minor Health 2018

Triple-Negative Breast Cancer, Stem Cells, and African Ancestry.
Evelyn Jiagge, Dhananjay Chitale, Lisa A Newman. Am J Pathol 2018

Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Foluso O Ademuyiwa, Yu Tao, Jingqin Luo, Katherine Weilbaecher, Cynthia X Ma. Breast Cancer Res Treat 2017

Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States.
Clement G Yedjou, Paul B Tchounwou, Marinelle Payton, Lucio Miele, Duber D Fonseca, Leroy Lowe, Richard A Alo. Int J Environ Res Public Health 2017

Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
M E Roseland, K Schwartz, J J Ruterbusch, L Lamerato, R Krajenta, J Booza, Michael S Simon. Breast Cancer Res Treat 2017

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.
Diana P Saraiva, M Guadalupe Cabral, António Jacinto, Sofia Braga. ESMO Open 2017